Business Context and Reporting Period
This Form 6-K filing is submitted by Genmab A/S, a foreign private issuer headquartered in Valby, Denmark. The report covers the month of February 2026 and was filed on February 18, 2026. The document serves primarily to incorporate a Company Announcement (Exhibit 99.1) by reference into the registrant's existing registration statements on Form S-8.
Key Financial Metrics
The provided filing text contains only cover page and signature information. It does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics. The specific financial data is contained within the referenced Exhibit 99.1, which is not included in the input text.
Material Changes
No material changes versus the prior comparable period can be identified from the provided text, as the filing does not disclose specific operational or financial results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements are presumed to be detailed in the Company Announcement (Exhibit 99.1) referenced in the exhibit index.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Company Announcement dated February 18, 2026) for the actual substance of the report.
- Confirm the specific nature of the announcement (e.g., clinical trial results, partnership updates, or financial restatements) as it is not described in the cover sheet.
- Review the referenced Form S-8 registration statements to understand the context of the incorporation by reference.